BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 18707547)

  • 1. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
    Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
    Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
    Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
    Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
    Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
    Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
    Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
    J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of residues in CD6 which are critical for ligand binding.
    Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
    Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action.
    Garner LI; Hartland A; Breuning J; Brown MH
    Immunology; 2018 Oct; 155(2):273-282. PubMed ID: 29772075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the CD6 ligand binding domain.
    Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
    Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
    J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
    Bowen MA; Aruffo AA; Bajorath J
    Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
    Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
    Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
    Nair P; Melarkode R; Rajkumar D; Montero E
    Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
    Osorio LM; Garcia CA; Jondal M; Chow SC
    Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD6 recognizes the neural adhesion molecule BEN.
    Skonier JE; Bowen MA; Aruffo A; Bajorath J
    Protein Sci; 1997 Aug; 6(8):1768-70. PubMed ID: 9260290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
    Robinson WH; Neuman de Vegvar HE; Prohaska SS; Rhee JW; Parnes JR
    Eur J Immunol; 1995 Oct; 25(10):2765-9. PubMed ID: 7589069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
    Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
    J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution of CD6 and CD6 ligand in cattle: expression of the CD6 ligand (CD166) in the autonomic nervous system of cattle and the human.
    Konno A; Ahn JS; Kitamura H; Hamilton MJ; Gebe JA; Aruffo A; Davis WC
    J Leukoc Biol; 2001 Jun; 69(6):944-50. PubMed ID: 11404380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
    Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
    Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6-ligand interactions: a paradigm for SRCR domain function?
    Aruffo A; Bowen MA; Patel DD; Haynes BF; Starling GC; Gebe JA; Bajorath J
    Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.
    Chappell PE; Garner LI; Yan J; Metcalfe C; Hatherley D; Johnson S; Robinson CV; Lea SM; Brown MH
    Structure; 2015 Aug; 23(8):1426-1436. PubMed ID: 26146185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule.
    Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
    Biochemistry; 1996 Nov; 35(47):14743-8. PubMed ID: 8942635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.